Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPE-1 for leukopenia and fatigue in breast cancer patients
NCT01142479Phase 3Completed
- Sponsor
- Taipei City Hospital
- Start
- May 2010
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of TPE-1 in leukopenia and cancer-related fatigue (CRF), sponsored by Taipei City Hospital. Started May 2010; status: completed.
02
Drugs
TPE-1
03
Conditions
leukopeniacancer-related fatigue (CRF)
Beyond the preview
Go deeper on NCT01142479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01142479.